INTRODUCTION: Chronic hepatitis C virus (HCV) infection is a significant public health problem. Strategies to identify more HCV infections and improve linkage to care (LTC) are needed. We compared characteristics, treatment and LTC among chronic HCV patients in different health care settings. METHODS: Newly diagnosed HCV antibody positive (anti-HCV+) patients within settings of acute care, inpatient and outpatient in one health system were studied. Proportion of LTC and treatment were analyzed only for HCV RNA positive patients. Chi-square, one-way ANOVA and logistic regression were used to compare the characteristics and outcomes in the three care settings. Patients in acute care settings were excluded from multivariate analyses due to low sample size. RESULTS: About 43, 368, and 1159 anti-HCV+ individuals were identified in acute care, inpatient, and outpatient, respectively. Proportion of RNA positivity in acute, inpatient, and outpatient were 47.8, 60.3 and 29.2%, respectively (p < 0.01). After adjusting for age, insurance type, race, and gender, outpatients had higher odds of LTC and of treatment (OR 4.7 [2.9, 7.6] and 4.5 [2.8, 7.3]). CONCLUSIONS: Inpatients had lower proportion of LTC and treatment compared to outpatients. Use of LTC coordinators and the provision of integrated service for specialty care may improve outcomes.
INTRODUCTION: Chronic hepatitis C virus (HCV) infection is a significant public health problem. Strategies to identify more HCV infections and improve linkage to care (LTC) are needed. We compared characteristics, treatment and LTC among chronic HCV patients in different health care settings. METHODS: Newly diagnosed HCV antibody positive (anti-HCV+) patients within settings of acute care, inpatient and outpatient in one health system were studied. Proportion of LTC and treatment were analyzed only for HCV RNA positive patients. Chi-square, one-way ANOVA and logistic regression were used to compare the characteristics and outcomes in the three care settings. Patients in acute care settings were excluded from multivariate analyses due to low sample size. RESULTS: About 43, 368, and 1159 anti-HCV+ individuals were identified in acute care, inpatient, and outpatient, respectively. Proportion of RNA positivity in acute, inpatient, and outpatient were 47.8, 60.3 and 29.2%, respectively (p < 0.01). After adjusting for age, insurance type, race, and gender, outpatients had higher odds of LTC and of treatment (OR 4.7 [2.9, 7.6] and 4.5 [2.8, 7.3]). CONCLUSIONS: Inpatients had lower proportion of LTC and treatment compared to outpatients. Use of LTC coordinators and the provision of integrated service for specialty care may improve outcomes.
Authors: Barbara S Taylor; Joshua T Hanson; Poornachand Veerapaneni; Roberto Villarreal; Kristin Fiebelkorn; Barbara J Turner Journal: Public Health Rep Date: 2016 May-Jun Impact factor: 2.792
Authors: Barbara J Turner; Barbara S Taylor; Joshua T Hanson; Mary Elizabeth Perez; Ludivina Hernandez; Roberto Villarreal; Poornachand Veerapaneni; Kristin Fiebelkorn Journal: J Hosp Med Date: 2015-05-29 Impact factor: 2.960
Authors: Gilberto Ramirez; Rebecca Cabral; Margaret Patterson; Ben T Schoenbachler; Deborah Bedell; Bryce D Smith; Claudia Vellozzi; Geoff A Beckett Journal: Public Health Rep Date: 2016 May-Jun Impact factor: 2.792
Authors: James W Galbraith; John P Donnelly; Ricardo A Franco; Edgar T Overton; Joel B Rodgers; Henry E Wang Journal: Clin Infect Dis Date: 2014-06-09 Impact factor: 9.079
Authors: Anouk T Urbanus; Thijs J van de Laar; Ineke G Stolte; Janke Schinkel; Titia Heijman; Roel A Coutinho; Maria Prins Journal: AIDS Date: 2009-07-31 Impact factor: 4.177
Authors: Francesca Romana Ponziani; Francesca Mangiola; Cecilia Binda; Maria Assunta Zocco; Massimo Siciliano; Antonio Grieco; Gian Lodovico Rapaccini; Maurizio Pompili; Antonio Gasbarrini Journal: World J Hepatol Date: 2017-03-08
Authors: Sabrina A Assoumou; Wei Huang; C Robert Horsburgh; Mari-Lynn Drainoni; Benjamin P Linas Journal: Open Forum Infect Dis Date: 2014-05-14 Impact factor: 4.423